Did you know there’s even more we can do to promote your episode? Find out more…
Imran Kausar, Founder of DeepHealth Consulting, joins the podcast to discuss gene therapies, their pricing, and the value they bring to patients.
James Lovett & Mike Cohen from Myonex join the podcast to share insights on driving success in clinical trials and fueling sustainable organic growth.
Dean McAlister, EVP at Inizio Biotech, joins the podcast live from J.P. Morgan 2025 to share insights on the life sciences sector outlook.
Discover what makes Piramal Global Pharma a standout in the CDMO space as CEO Peter DeYoung reveals their “secret sauce” to success.
Ian Tzeng, Managing Director & Partner at L.E.K., joins the podcast to discuss the outlook for 2025 in the pharma services sector.
In this special episode, Raman takes the hot seat and is interviewed by JoyL Silva to commemorate 200 episodes of Molecule to Market.
Kerstin Dolph, SVP of Manufacturing at Charles River Labs, shares insights from her 23-year journey and diverse roles at the business.
Jack Stine, CEO at Savendor, shares his journey and motivations for launching his own business in the pharma outsourcing industry.
Tessa Pugh, ex-CEO at PharmaReview, shares her journey from co-founder to CEO, driving growth and leading a PE-backed exit to IQVIA.
Camila Easter, CEO at Oxford Medical Products, shares her journey from the veterinary field to making waves in the GLP-1 space.